Send me a link:

*Text messaging rates may apply.

 Dow Down 0.86% Nasdaq Down 0.59%

Idera Pharmaceuticals, Inc. (IDRA)

-NasdaqCM
2.64 Down 0.11(3.83%) 1:31PM EDT - Nasdaq Real Time Price
Prev Close:2.75
Open:2.74
Bid:2.63 x 6900
Ask:2.64 x 700
1y Target Est:7.00
Beta:3.32
Next Earnings Date:N/A
Day's Range:2.61 - 2.74
52wk Range:0.87 - 6.87
Volume:517,940
Avg Vol (3m):1,807,240
Market Cap:217.65M
P/E (ttm):N/A
EPS (ttm):-0.47
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for IDRA

Comparison

Symbol% ChgMkt Cap
IDRADown 3.83%217.65M
DVAXDown 1.42%365.37M
PFEDown 0.79%192.00B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):5,262.87
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.40
Quarterly EPS Est (Jun-14) :-0.09
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Idera Pharmaceuticals, Inc., a clinical stage biotechnology company, is engaged in the discovery and development of novel therapeutics that modulate immune responses through toll-like receptors (TLRs) in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback